ArticleCurrent opinion in biomedical engineering2021
2D layered nanomaterials for therapeutics delivery.
Article in Current opinion in biomedical engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- NbRSC advances · 2026Article
- Multi-scale computational insights into West Nile virus E-protein adsorption on graphene and phosphorene nanomaterials.Nanoscale advances · 2026Article
- Designing the Next Generation of Biomaterials through Nanoengineering.Advanced materials (Deerfield Beach, Fla.) · 2025Review
- Nanosilicates promote angiogenesis through activation of ROS-mediated WNT/β-catenin pathway.Science advances · 2025Article
- Magnetic 2D Transition-Metal-Based Nanomaterials in Biomedicine: Opportunities and Challenges in Cancer Therapy.Materials (Basel, Switzerland) · 2025Review
- Current Trends and Advances in Nanoplatforms-Based Imaging for Cancer Diagnosis.Indian journal of microbiology · 2025Article
- Emerging trends and future challenges of advanced 2D nanomaterials for combating bacterial resistance.Bioactive materials · 2024Review
- Emerging Two-Dimensional Ti3C2-BiOCl Nanoparticles for Excellent Antimicrobial and Antioxidant Properties.Cureus · 2024Article
- DFT study of TiRSC advances · 2024Article
- Review
- Laponite-Based Nanocomposite Hydrogels for Drug Delivery Applications.Pharmaceuticals (Basel, Switzerland) · 2023Review
- Natural and Synthetic Clay Minerals in the Pharmaceutical and Biomedical Fields.Pharmaceutics · 2023Review
- Nanomaterials for Skin Cancer Photoimmunotherapy.Biomedicines · 2023Review
- Laponite intercalated biomimetic multilayer coating prevents glucocorticoids induced orthopedic implant failure.Bioactive materials · 2023Article
- Advances of Mussel-Inspired Nanocomposite Hydrogels in Biomedical Applications.Biomimetics (Basel, Switzerland) · 2023Review
- Nano-bio interactions of 2D molybdenum disulfide.Advanced drug delivery reviews · 2022Review
- Understanding interactions between biomolecules and two-dimensional nanomaterials using in silico microscopes.Advanced drug delivery reviews · 2022Review
- Advances in Biologically Applicable Graphene-Based 2D Nanomaterials.International journal of molecular sciences · 2022Review
- 2D Covalent Organic Framework Direct Osteogenic Differentiation of Stem Cells.Advanced healthcare materials · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Two-dimensional (2D) nanomaterials are ultrathin, layered materials with a high surface-to-volume ratio that can deliver various therapeutics including small-molecule drugs, peptides, and large proteins. Their high surface area allows for high therapeutic loading and sustained therapeutic release over time. Some 2D nanomaterials respond to external stimuli, providing control over triggered or on-demand therapeutic release. 2D nanomaterials explored for biomedical applications include carbon-based (graphene), nanoclays, black phosphorous, layered double hydroxides, metal organic frameworks, covalent organic framework, 2D metal carbides and nitrides, transition metal dichalcogenides, transition metal oxides, polymer nanosheets, and hexagonal boron nitride. Most of these nanomaterials are biocompatible and degrade into nontoxic products, which is advantageous for therapeutic delivery systems. In this article, we will evaluate these nanomaterials for therapeutic delivery. We will highlight some of their unique physical and chemical characteristics, discuss their biological stability, and investigate their ability to deliver various therapeutics. Recent developments in 2D nanomaterials as drug delivery systems will also be discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.